Characteristic . | Azithromycin Group (n = 226) . | Placebo Group (n = 235) . | P Value . |
---|---|---|---|
Maternal age at delivery, mean (SD) | 26.5 (5.3)a | 26.6 (5.0) | .684 |
Mode of delivery | |||
Vaginal | 220 (97.4) | 233 (99.2) | .165 |
Cesarean | 6 (2.7) | 2 (0.9) | |
Information at birth | |||
Multiple pregnancy | 2 (0.9) | 10 (4.3) | .037 |
Sexb | |||
Female | 117 (51.8) | 104 (44.3) | .266 |
Male | 107 (47.4) | 124 (52.8) | |
Ethnicityc | |||
Mandinka | 93 (41.2) | 106 (45.1) | .490 |
Jola | 44 (19.5) | 36 (15.3) | |
Wollof | 26 (11.5) | 23 (9.8) | |
Fula | 37 (16.4) | 38 (16.2) | |
Others | 24 (10.6) | 31 (13.2) | |
Season | |||
Dry | 178 (78.8) | 188 (80.0) | .909 |
Wet | 48 (21.2) | 47 (20.0) | |
Child age at follow-up visit, mean (SD) | 12.24 (0.6) | 12.27 (0.6) | .486 |
Characteristic . | Azithromycin Group (n = 226) . | Placebo Group (n = 235) . | P Value . |
---|---|---|---|
Maternal age at delivery, mean (SD) | 26.5 (5.3)a | 26.6 (5.0) | .684 |
Mode of delivery | |||
Vaginal | 220 (97.4) | 233 (99.2) | .165 |
Cesarean | 6 (2.7) | 2 (0.9) | |
Information at birth | |||
Multiple pregnancy | 2 (0.9) | 10 (4.3) | .037 |
Sexb | |||
Female | 117 (51.8) | 104 (44.3) | .266 |
Male | 107 (47.4) | 124 (52.8) | |
Ethnicityc | |||
Mandinka | 93 (41.2) | 106 (45.1) | .490 |
Jola | 44 (19.5) | 36 (15.3) | |
Wollof | 26 (11.5) | 23 (9.8) | |
Fula | 37 (16.4) | 38 (16.2) | |
Others | 24 (10.6) | 31 (13.2) | |
Season | |||
Dry | 178 (78.8) | 188 (80.0) | .909 |
Wet | 48 (21.2) | 47 (20.0) | |
Child age at follow-up visit, mean (SD) | 12.24 (0.6) | 12.27 (0.6) | .486 |
Data are presented as No. (%) unless otherwise indicated.
Abbreviation: SD, standard deviation.
aThree missing data in the azithromycin arm.
bNine missing data (2 in the azithromycin arm and 7 in the placebo arm).
cThree missing data (2 in the azithromycin arm and 1 in the placebo arm).
Characteristic . | Azithromycin Group (n = 226) . | Placebo Group (n = 235) . | P Value . |
---|---|---|---|
Maternal age at delivery, mean (SD) | 26.5 (5.3)a | 26.6 (5.0) | .684 |
Mode of delivery | |||
Vaginal | 220 (97.4) | 233 (99.2) | .165 |
Cesarean | 6 (2.7) | 2 (0.9) | |
Information at birth | |||
Multiple pregnancy | 2 (0.9) | 10 (4.3) | .037 |
Sexb | |||
Female | 117 (51.8) | 104 (44.3) | .266 |
Male | 107 (47.4) | 124 (52.8) | |
Ethnicityc | |||
Mandinka | 93 (41.2) | 106 (45.1) | .490 |
Jola | 44 (19.5) | 36 (15.3) | |
Wollof | 26 (11.5) | 23 (9.8) | |
Fula | 37 (16.4) | 38 (16.2) | |
Others | 24 (10.6) | 31 (13.2) | |
Season | |||
Dry | 178 (78.8) | 188 (80.0) | .909 |
Wet | 48 (21.2) | 47 (20.0) | |
Child age at follow-up visit, mean (SD) | 12.24 (0.6) | 12.27 (0.6) | .486 |
Characteristic . | Azithromycin Group (n = 226) . | Placebo Group (n = 235) . | P Value . |
---|---|---|---|
Maternal age at delivery, mean (SD) | 26.5 (5.3)a | 26.6 (5.0) | .684 |
Mode of delivery | |||
Vaginal | 220 (97.4) | 233 (99.2) | .165 |
Cesarean | 6 (2.7) | 2 (0.9) | |
Information at birth | |||
Multiple pregnancy | 2 (0.9) | 10 (4.3) | .037 |
Sexb | |||
Female | 117 (51.8) | 104 (44.3) | .266 |
Male | 107 (47.4) | 124 (52.8) | |
Ethnicityc | |||
Mandinka | 93 (41.2) | 106 (45.1) | .490 |
Jola | 44 (19.5) | 36 (15.3) | |
Wollof | 26 (11.5) | 23 (9.8) | |
Fula | 37 (16.4) | 38 (16.2) | |
Others | 24 (10.6) | 31 (13.2) | |
Season | |||
Dry | 178 (78.8) | 188 (80.0) | .909 |
Wet | 48 (21.2) | 47 (20.0) | |
Child age at follow-up visit, mean (SD) | 12.24 (0.6) | 12.27 (0.6) | .486 |
Data are presented as No. (%) unless otherwise indicated.
Abbreviation: SD, standard deviation.
aThree missing data in the azithromycin arm.
bNine missing data (2 in the azithromycin arm and 7 in the placebo arm).
cThree missing data (2 in the azithromycin arm and 1 in the placebo arm).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.